Defective Breast Mesh, Acellular Dermal Matrix (ADM), and Bioabsorbable Scaffold Injury Attorneys in Mississippi: The Complete Guide for Women, Families, and Survivors

For women across Mississippi who have undergone breast reconstruction following a mastectomy or sought aesthetic improvement through breast augmentation, the expectation is one of healing, restoration, and renewed confidence. Whether you received care at the University of Mississippi Medical Center (UMMC) in Jackson, St. Dominic Hospital, or any of the specialized surgical centers from the Gulf Coast to the Delta, you placed your trust in the medical devices implanted in your body. We understand that for many Mississippi patients, that trust has been shattered by complications involving surgical mesh, acellular dermal matrix (ADM), and bioabsorbable scaffolds products that were often marketed as safe but never received formal FDA approval for use in breast tissue.

At The Manginello Law Firm, PLLC, operating under the brand Attorney911, we know that the physical and emotional toll of reconstruction failure or a cancer diagnosis like BIA-ALCL is devastating. If you are currently dealing with skin-flap necrosis, persistent seroma, or the systemic symptoms of breast implant illness in Mississippi, you are not alone. Our managing partner, Ralph Manginello, has spent twenty-seven years fighting for the rights of the injured. Admitted to the United States District Court for the Southern District of Texas and licensed since 1998 (Bar Card Number 24007597), Ralph brings a career’s worth of litigation experience to every medical device case we handle. We serve clients across Mississippi, helping them navigate the complex federal litigation landscape that governs defective medical products.

This guide is designed to be the definitive resource for Mississippi families. We will examine the regulatory failures of the FDA 510(k) pathway, the specific brands like GalaFLEX and Phasix currently under scrutiny, and the legal pathways available to you. If your life has been upended by a defective breast scaffold or ADM product, contact us today at 1-888-ATTY-911 for a confidential, no-obligation consultation.

Understanding the Devices: Mesh, ADM, and Scaffolds in Mississippi Breast Surgery

The nomenclature used in breast surgery can be confusing for patients. In Mississippi surgical suites, surgeons often use these materials to provide a “hammock” or “internal bra” support for a breast implant or tissue expander.

Acellular Dermal Matrix (ADM) is a biologic material, typically human or porcine (pig) skin that has been processed to remove all cells while leaving the structural collagen matrix intact. Common brands used in Mississippi hospitals include AlloDerm, Strattice, and FlexHD. Bioabsorbable Scaffolds, such as GalaFLEX and Phasix, are synthetic products made from polymers like poly-4-hydroxybutyrate (P4HB). These are designed to provide temporary support and then slowly dissolve as your body’s own tissue takes over. Finally, traditional surgical mesh is often a permanent synthetic material, like polypropylene, which has a long and troubled history in other areas of litigation.

The core issue many Mississippi women face is that the FDA has never cleared or approved any of these surgical mesh products specifically for use in breast surgery. Instead, they reached the market through the 510(k) “substantial equivalence” pathway, claiming they were similar to general-use hernia mesh or even surgical sutures. This regulatory shortcut allowed manufacturers to bypass the rigorous clinical trials that would have revealed high rates of infection and reconstruction failure before these devices were implanted in your body.

The Brand Universe: Products Implicated in Mississippi Device Injuries

We are investigating claims involving a wide array of manufacturers who may have prioritized market share over the safety of Mississippi patients. These brands include:

• Becton Dickinson (BD) / C.R. Bard: Manufacturers of GalaFLEX, GalaFLEX Lite, and Phasix Mesh. These P4HB products are the focus of emerging litigation due to the whistleblower testimony of Dr. Hooman Noorchashm, who alleged that the company withheld data regarding breast cancer recurrences.
• Allergan (AbbVie): The company responsible for the Natrelle BIOCELL textured breast implants, which were subject to a massive 2019 recall due to their clear association with BIA-ALCL. They also manufacture AlloDerm and Strattice ADM.
• MTF Biologics: The maker of FlexHD and FlexHD Pliable, which the FDA explicitly named in 2021 as having significantly higher rates of reoperation and infection.
• Integra LifeSciences: Manufacturer of SurgiMend and the newly acquired DuraSorb Monofilament Mesh.
• Mentor (Johnson & Johnson): Makers of silicone-gel breast implants that were the subject of an FDA warning letter regarding failed post-market studies.

If you recognize these names from your Mississippi operative reports, it is essential to understand that your complications may be linked to the design or marketing of the product itself, not necessarily a mistake by your surgeon. Our team, including associate attorney Lupe Peña, is prepared to examine your records. Lupe, a third-generation Texan and South Texas College of Law graduate (Bar Card Number 24084332), provides a unique advantage for our Spanish-speaking clients. We conduct full consultations in Spanish, ensuring that language is never a barrier to justice for any woman in Mississippi. You can reach us at 888-ATTY-911 to discuss your device history.

The FDA Regulatory Failure: What Mississippi Patients Weren’t Told

The regulatory landscape of medical devices is governed by the Federal Food, Drug, and Cosmetic Act. Most Mississippi women assume that if a device is in an operating room, the FDA has “approved” it as safe. However, the 510(k) pathway (21 USC §360c) only requires a manufacturer to show that a device is “substantively equivalent” to a predicate device. This has led to “predicate creep,” where a breast scaffold like GalaFLEX is cleared by comparing it to a suture, even though its use in the breast environment is entirely different.

The FDA’s November 9, 2023 letter to health care providers was a watershed moment for Mississippi patients. In that letter, the FDA stated verbatim that “the safety and effectiveness of surgical mesh in breast surgery… has not been determined by the FDA.” This admission came years after thousands of women had already suffered catastrophic injuries. We focus our practice on holding these manufacturers accountable for failing to warn both surgeons and patients in Mississippi about these known risks. Ralph Manginello’s twenty-seven years of experience is critical here; he understands how to navigate the preemption defenses manufacturers often use to try and block lawsuits. Under Medtronic v. Lohr (518 U.S. 470), 510(k)-cleared devices are generally not entitled to the same level of federal preemption as those that underwent the full Premarket Approval (PMA) process, leaving the door open for Mississippi survivors to seek compensation.

Serious Complications: From Red Breast Syndrome to BIA-ALCL

Complications from these devices in Mississippi can range from painful aesthetic failures to life-threatening malignancies. We are currently representing patients dealing with:

Red Breast Syndrome and Endotoxin Science

Many ADM products, particularly those that are not terminally sterilized, can carry bacterial endotoxins. This can trigger Red Breast Syndrome—a non-infectious, sterile inflammation of the skin over the ADM. Unlike a typical infection, it does not respond to antibiotics and often requires the removal of the matrix and the implant.

Reconstruction Failure and Skin-Flap Necrosis

Acellular dermal matrices and scaffolds can interfere with the blood supply to the skin of the breast (the skin flap). In Mississippi clinical settings, this often leads to necrosis—the death of the tissue. This results in horrific scarring, the loss of the reconstruction, and often the loss of the breast envelope entirely, leaving the patient with no choice but a flat closure.

BIA-ALCL and BIA-SCC (Breast Implant-Associated Cancers)

The most severe risk is the development of Anaplastic Large Cell Lymphoma (BIA-ALCL). This is a CD30-positive, ALK-negative T-cell lymphoma that forms in the scar tissue (capsule) around the implant. Symptoms typically appear 7 to 10 years after surgery and include sudden swelling (seroma) or a mass. The World Health Organization has recognized this as a distinct lymphoma since 2016. Furthermore, the FDA alerted the public in September 2022 to the emergence of Squamous Cell Carcinoma (BIA-SCC) in implant capsules, a different and often more aggressive cancer.

If you have been diagnosed with a malignancy or are facing a third or fourth “salvage” surgery in Mississippi, we are here to help. Call 1-888-ATTY-911 to speak with our team. We understand the pathology and the science, and we use that knowledge to build a powerful case for your recovery.

Why The Manginello Law Firm is the Choice for Mississippi Survivors

Choosing the right attorney for a defective medical device case in Mississippi is a decision that affects the rest of your life. Generalist personal injury firms often lack the substantive command of the FDA Manufacturer and User Facility Device Experience (MAUDE) database or the nuances of the Riegel/Lohr/Buckman preemption canon.

Ralph Manginello is a member of the Pro Bono College of the State Bar of Texas, a recognition for those who exceed seventy-five hours of service annually. Our firm is currently lead counsel in high-profile institutional litigation, such as Bermudez v. Pi Kappa Phi, where we are seeking $10,000,000 in damages following a hazing incident that resulted in the University of Houston shutting down a chapter. This case demonstrates our ability to prosecute complex, multi-defendant litigation against large, well-funded entities—exactly the type of structure required for a successful breast mesh or scaffold lawsuit in Mississippi.

Our firm holds an aggregate 4.9 out of 5.0 rating across nearly 500 Birdeye reviews, and Ralph Manginello maintains an 8.2 “Excellent” rating on Avvo. We are established, we are proven, and we are dedicated to helping women in Mississippi. Whether you’re in the Southern District of Mississippi (Jackson and Gulfcoast) or the Northern District (Oxford and the Delta), we have the federal court experience to manage your claim.

The Whistleblower evidence: Dr. Hooman Noorchashm’s Public Record

Mississippi patients deserve to know what was happening behind the scenes at companies like Becton Dickinson. Dr. Hooman Noorchashm, a cardiothoracic surgeon and former BD Medical Director, became a whistleblower after raising safety concerns about the GalaFLEX product line. He alleged that the company withheld evidence of breast cancer recurrences in patients and failed to properly report adverse events to the FDA.

Dr. Noorchashm’s work has highlighted “predicate creep” and the dangers of using non-standardized products in the sensitive environment of breast cancer reconstruction. His public record is a crucial piece of evidence for Mississippi plaintiffs, demonstrating that the risks were known to insiders but concealed from the surgeons and patients in cities like Jackson and Biloxi. We utilize this whistleblower data to penetrate the defense narrative that these complications were unforeseen or “unavoidable.”

Legal Rights and Statutes of Limitations in Mississippi

If you have been injured by a defective medical device in Mississippi, time is of the essence. Mississippi law generally imposes a three-year statute of limitations for personal injury and product liability claims. However, the “discovery rule” may apply. This means the clock might not start until you knew, or reasonably should have discovered, that your injury was caused by the defective nature of the mesh or scaffold.

Because of the 2023 FDA labeling update and recent safety communications, many Mississippi women are only now realizing that their prior surgical failures were linked to a defective product. This “recent discovery” is a critical legal lever that we use to protect your right to file a claim, even if your original surgery was years ago. However, the only way to be certain of your deadline is to have a lawyer review your specific medical timeline. The sooner you call 1-888-288-9911, the sooner we can secure your operative reports and preserve necessary evidence like explanted devices and pathology slides.

Damages: What Mississippi Families Can Recover

A successful lawsuit can provide the financial resources necessary to move forward. In Mississippi, damages in these cases typically include:

• Medical Expenses: Coverage for past and future surgeries, hyperbaric oxygen therapy, IV antibiotics, and specialist consultations.
• Lost Wages: Compensation for the time you missed work while recovering from complications or revision surgeries.
• Pain and Suffering: Recognition of the physical agony and emotional distress caused by chronic pain, infection, and the fear of cancer.
• Permanent Disfigurement: Compensation for the visible scarring and loss of the breast that impacts your self-image and quality of life.
• Punitive Damages: In cases where we can prove a manufacturer consciously disregarded the safety of Mississippi patients, we may seek punitive damages to punish the company and prevent future harm.

We operate on a contingency fee basis. This means we charge no upfront fees, and you pay nothing unless we recover compensation for you. This allows Mississippi survivors of all financial backgrounds to have the same “heavy-hitter” representation as the giant medical device corporations. Call 1-888-ATTY-911 to get started.

Frequently Asked Questions for Mississippi Patients

Is surgical mesh actually approved by the FDA for breast surgery?
No. As of today, the FDA has not cleared or approved any surgical mesh, ADM, or scaffold product specifically for use in breast reconstruction or augmentation. They are used “off-label” by Mississippi surgeons.

What if my surgeon told me the device was safe?
Surgeons often rely on the information provided by the manufacturer’s sales representatives. If the manufacturer withheld safety data (as alleged in the BD whistleblower case), your surgeon was just as misled as you were. In many Mississippi cases, the manufacturer—not the doctor—is the primary target of the litigation.

How do I find out which brand of mesh was used in my Mississippi surgery?
You have a legal right to your medical records. We can assist you in requesting your “Operative Report” and “Implant Log.” These documents contain the Unique Device Identifier (UDI) stickers that name the brand, lot number, and manufacturer.

Is there a class action lawsuit for breast mesh in Mississippi?
Most medical device cases are handled as individual lawsuits or consolidated into Multidistrict Litigation (MDL). For example, the Allergan BIOCELL cases are part of MDL 2921. Individual claims are often better for patients because they allow for compensation based on your specific level of injury.

Can I sue if I have “Breast Implant Illness” but not cancer?
Yes. If you have systemic symptoms like chronic fatigue, joint pain, and brain fog that resolved after the removal of your implants and mesh, you may have a claim based on a failure to warn about these potential immunological reactions.

What does it cost to start my case with Attorney911?
It costs nothing out of pocket. We provide free consultations for all Mississippi residents, and we only get paid if we win your case. You can reach us 24/7 at 1-888-ATTY-911.

Contact a Mississippi Defective Breast Device Attorney Today

At The Manginello Law Firm, PLLC, we believe that every woman who undergoes breast surgery in Mississippi deserves the truth about the products being used in her body. When manufacturers choose profit over patient safety, they must be held accountable. Whether you are a breast cancer survivor who has lost her reconstruction at UMMC or a cosmetic patient dealing with a painful internal bra failure, we are ready to stand with you.

Our managing partner, Ralph Manginello, and our dedicated team are prepared to fight for the maximum compensation available to you. We have the resources, the technical knowledge, and the litigation experience to take on the giants of the medical device industry.

No importa dónde se encuentre en Mississippi o qué idioma hable, estamos aquí para escuchar su historia. Lupe Peña y nuestro equipo bilingüe están listos para ayudarle.

Take the first step toward justice. Document your symptoms, preserve your records, and call us at 1-888-ATTY-911 or (888) 288-9911. You can also visit our principal office at 1177 West Loop South, Suite 1600, Houston, Texas 77027, or contact us through our website. We are your advocates, your educators, and your voice in the courtroom.

Past results do not guarantee future outcomes. Every case is unique and depends on the specific facts and Mississippi law. This content is for educational purposes and does not constitute medical or legal advice. An attorney-client relationship is only formed through a signed written agreement with The Manginello Law Firm, PLLC.